Curemark To Enroll Children 9-12 Years Of Age Into Medical Trial Of CM-AT For Children With Autism
06:22 EDT 6 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
NEW YORK, Aug. 6, 2012 /PRNewswire/ -- Dr. Joan Fallon, founder and CEO of Curemark, a Rye, New York-based drug research and development company focused on the treatment of Autism and neurological diseases, today announced that the company has rece...
Other Sources for this Article
More From BioPortfolio on "Curemark To Enroll Children 9-12 Years Of Age Into Medical Trial Of CM-AT For Children With Autism"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
